Covid-19: Cuba’s Soberana-2 vaccine starts phase 3 trials
The Cuban government has announced that Soberana-2 will commence Phase III trials on 44,000 participants in March HAVANA, March 5 (NNN-AGENCIES) — Cuba on Thursday started phase 3 clinical trials of its Soberana-2 COVID-19 vaccine, Vicente Verez, director general of Cuba’s Finlay Institute of Vaccines, told a press conference. “We…
